Takeda, Iambic sign multiyear R&D deal for AI drug discoverynews2026-02-09T13:00:13+00:00February 9th, 2026|Endpoints News|
Flagship’s Generate:Biomedicines files for IPO, pitching AI-driven drugsnews2026-02-05T12:00:39+00:00February 5th, 2026|Endpoints News|
Menlo and a16z back AI scientist startup Phylonews2026-02-03T12:00:21+00:00February 3rd, 2026|Endpoints News|
Following Abivax, Formation Bio licenses miR-124 drug from Chinanews2026-01-29T12:00:49+00:00January 29th, 2026|Endpoints News|
BioMarin vets spearhead new biotech with $82M for rare disease drugsnews2026-01-22T12:00:19+00:00January 22nd, 2026|Endpoints News|
Teladoc’s mental health arm BetterHelp has quietly expanded the use of AInews2026-01-20T13:00:44+00:00January 20th, 2026|Endpoints News|
J&J, Isomorphic sign research deal for AI-made moleculesnews2026-01-20T12:00:09+00:00January 20th, 2026|Endpoints News|
Nvidia-partnered startup reveals AI-generated enzymes for precise gene insertionnews2026-01-12T21:18:10+00:00January 12th, 2026|Endpoints News|
Eli Lilly, Nvidia sign five-year, up to $1B deal for AI laboratorynews2026-01-12T15:00:19+00:00January 12th, 2026|Endpoints News|
Eli Lilly, Chai Discovery sign AI software dealnews2026-01-09T12:00:23+00:00January 9th, 2026|Endpoints News|
